INMODE LTD (INMD)
IL0011595993 - Common Stock
Overall INMD gets a fundamental rating of 6 out of 10. We evaluated INMD against 187 industry peers in the Health Care Equipment & Supplies industry. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. INMD has a bad growth rate and is valued cheaply. This makes INMD very considerable for value investing!
1. Profitability
1.1 Basic Checks
INMD had positive earnings in the past year.
In the past year INMD had a positive cash flow from operations.
In the past 5 years INMD has always been profitable.
INMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 18.65%, INMD belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
The Return On Equity of INMD (20.85%) is better than 95.19% of its industry peers.
INMD's Return On Invested Capital of 15.55% is amongst the best of the industry. INMD outperforms 96.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 8.19%.
The last Return On Invested Capital (15.55%) for INMD is well below the 3 year average (28.25%), which needs to be investigated, but indicates that INMD had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.65% | ||
| ROE | 20.85% | ||
| ROIC | 15.56% |
ROA(3y)27.49%
ROA(5y)27.16%
ROE(3y)31.31%
ROE(5y)31.63%
ROIC(3y)28.25%
ROIC(5y)27.22%
1.3 Margins
INMD has a Profit Margin of 36.26%. This is amongst the best in the industry. INMD outperforms 98.40% of its industry peers.
In the last couple of years the Profit Margin of INMD has grown nicely.
INMD has a Operating Margin of 32.07%. This is amongst the best in the industry. INMD outperforms 98.93% of its industry peers.
INMD's Operating Margin has improved in the last couple of years.
INMD has a better Gross Margin (81.64%) than 94.12% of its industry peers.
In the last couple of years the Gross Margin of INMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.07% | ||
| PM (TTM) | 36.26% | ||
| GM | 81.64% |
OM growth 3Y4.03%
OM growth 5Y4.81%
PM growth 3Y3.39%
PM growth 5Y12.47%
GM growth 3Y-0.57%
GM growth 5Y-0.32%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INMD is creating value.
Compared to 1 year ago, INMD has more shares outstanding
The number of shares outstanding for INMD has been increased compared to 5 years ago.
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.66
WACC9.36%
2.3 Liquidity
INMD has a Current Ratio of 10.68. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.68, INMD belongs to the best of the industry, outperforming 93.58% of the companies in the same industry.
A Quick Ratio of 9.91 indicates that INMD has no problem at all paying its short term obligations.
INMD has a Quick ratio of 9.91. This is amongst the best in the industry. INMD outperforms 93.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.68 | ||
| Quick Ratio | 9.91 |
3. Growth
3.1 Past
The earnings per share for INMD have decreased strongly by -21.29% in the last year.
The Earnings Per Share has been growing by 45.76% on average over the past years. This is a very strong growth
Looking at the last year, INMD shows a very negative growth in Revenue. The Revenue has decreased by -15.06% in the last year.
The Revenue has been growing by 37.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-21.29%
EPS 3Y34.38%
EPS 5Y45.76%
EPS Q2Q%14.75%
Revenue 1Y (TTM)-15.06%
Revenue growth 3Y33.65%
Revenue growth 5Y37.48%
Sales Q2Q%5.78%
3.2 Future
INMD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.68% yearly.
INMD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.69% yearly.
EPS Next Y-23.1%
EPS Next 2Y-8.26%
EPS Next 3Y-2.68%
EPS Next 5YN/A
Revenue Next Year-16.13%
Revenue Next 2Y-7%
Revenue Next 3Y-2.69%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.19 indicates a reasonable valuation of INMD.
Based on the Price/Earnings ratio, INMD is valued cheaply inside the industry as 98.93% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.29. INMD is valued rather cheaply when compared to this.
INMD is valuated cheaply with a Price/Forward Earnings ratio of 7.87.
98.93% of the companies in the same industry are more expensive than INMD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of INMD to the average of the S&P500 Index (23.78), we can say INMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.19 | ||
| Fwd PE | 7.87 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INMD is valued cheaper than 98.40% of the companies in the same industry.
INMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INMD is cheaper than 98.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.03 | ||
| EV/EBITDA | 2.46 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as INMD's earnings are expected to decrease with -2.68% in the coming years.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-8.26%
EPS Next 3Y-2.68%
5. Dividend
5.1 Amount
No dividends for INMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INMODE LTD
NASDAQ:INMD (12/23/2024, 8:12:32 PM)
After market: 17.19 +0.24 (+1.42%)16.95
-0.13 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.77%
Inst Owner Change-12.23%
Ins Owners6.86%
Ins Owner ChangeN/A
Market Cap1.29B
Analysts78.46
Price Target21.76 (28.38%)
Short Float %8.69%
Short Ratio5.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.14%
Min EPS beat(2)-13.16%
Max EPS beat(2)8.88%
EPS beat(4)2
Avg EPS beat(4)-5.78%
Min EPS beat(4)-23.01%
Max EPS beat(4)8.88%
EPS beat(8)5
Avg EPS beat(8)0.44%
EPS beat(12)9
Avg EPS beat(12)3.72%
EPS beat(16)13
Avg EPS beat(16)7.31%
Revenue beat(2)1
Avg Revenue beat(2)-8.05%
Min Revenue beat(2)-16.64%
Max Revenue beat(2)0.53%
Revenue beat(4)1
Avg Revenue beat(4)-8.02%
Min Revenue beat(4)-16.64%
Max Revenue beat(4)0.53%
Revenue beat(8)4
Avg Revenue beat(8)-4.46%
Revenue beat(12)8
Avg Revenue beat(12)-1.01%
Revenue beat(16)12
Avg Revenue beat(16)1.13%
PT rev (1m)2.4%
PT rev (3m)1.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.72%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.19 | ||
| Fwd PE | 7.87 | ||
| P/S | 3.05 | ||
| P/FCF | 8.03 | ||
| P/OCF | 8.01 | ||
| P/B | 1.75 | ||
| P/tB | 1.75 | ||
| EV/EBITDA | 2.46 |
EPS(TTM)2.07
EY12.21%
EPS(NY)2.15
Fwd EY12.71%
FCF(TTM)2.11
FCFY12.46%
OCF(TTM)2.12
OCFY12.49%
SpS5.56
BVpS9.66
TBVpS9.66
PEG (NY)N/A
PEG (5Y)0.18
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.65% | ||
| ROE | 20.85% | ||
| ROCE | 18.16% | ||
| ROIC | 15.56% | ||
| ROICexc | 183.47% | ||
| ROICexgc | 183.47% | ||
| OM | 32.07% | ||
| PM (TTM) | 36.26% | ||
| GM | 81.64% | ||
| FCFM | 38% |
ROA(3y)27.49%
ROA(5y)27.16%
ROE(3y)31.31%
ROE(5y)31.63%
ROIC(3y)28.25%
ROIC(5y)27.22%
ROICexc(3y)916.5%
ROICexc(5y)N/A
ROICexgc(3y)916.5%
ROICexgc(5y)N/A
ROCE(3y)32.98%
ROCE(5y)31.78%
ROICexcg growth 3Y-75.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y-75.89%
ROICexc growth 5YN/A
OM growth 3Y4.03%
OM growth 5Y4.81%
PM growth 3Y3.39%
PM growth 5Y12.47%
GM growth 3Y-0.57%
GM growth 5Y-0.32%
F-Score5
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 72.97% | ||
| Cap/Sales | 0.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 118.27% | ||
| Profit Quality | 104.78% | ||
| Current Ratio | 10.68 | ||
| Quick Ratio | 9.91 | ||
| Altman-Z | N/A |
F-Score5
WACC9.36%
ROIC/WACC1.66
Cap/Depr(3y)173.91%
Cap/Depr(5y)176.01%
Cap/Sales(3y)0.25%
Cap/Sales(5y)0.29%
Profit Quality(3y)101.97%
Profit Quality(5y)102.3%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.29%
EPS 3Y34.38%
EPS 5Y45.76%
EPS Q2Q%14.75%
EPS Next Y-23.1%
EPS Next 2Y-8.26%
EPS Next 3Y-2.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.06%
Revenue growth 3Y33.65%
Revenue growth 5Y37.48%
Sales Q2Q%5.78%
Revenue Next Year-16.13%
Revenue Next 2Y-7%
Revenue Next 3Y-2.69%
Revenue Next 5YN/A
EBIT growth 1Y-33.47%
EBIT growth 3Y39.03%
EBIT growth 5Y44.09%
EBIT Next Year-34.47%
EBIT Next 3Y-8.06%
EBIT Next 5YN/A
FCF growth 1Y-8.52%
FCF growth 3Y30.8%
FCF growth 5Y36.99%
OCF growth 1Y-8.94%
OCF growth 3Y30.7%
OCF growth 5Y36.81%